Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1856 1
1891 1
1920 1
1936 1
1949 2
1964 10
1969 5
1971 4
1978 4
1980 4
1981 1
1982 1
1983 6
1984 1
1995 1
1997 1
2000 1
2001 2
2003 1
2004 2
2005 1
2007 1
2008 3
2009 5
2010 9
2011 8
2012 6
2013 22
2014 24
2015 22
2016 27
2017 31
2018 31
2019 44
2020 66
2021 59
2022 51
2023 22
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 31004040

431 results

Results by year

Filters applied: . Clear all
Page 1
PDA Biosimilars Workshop Report (September 27-28, 2018)-Getting It Right the First Time for Biosimilar Marketing Applications.
Krause S, Lacana E, Welch J, Shapiro M, Downey C, Chung J, Zhou Q, Van Der Plas M, Depatie C, Ingram B, Srebalus-Barnes C, Polozova A, Rellahan B, Choi D, Burdick R, Stangler T, Shacter E. Krause S, et al. PDA J Pharm Sci Technol. 2019 Jul-Aug;73(4):401-416. doi: 10.5731/pdajpst.2019.010215. Epub 2019 Apr 19. PDA J Pharm Sci Technol. 2019. PMID: 31004040
Biosimilar safety factors in clinical practice.
Reinisch W, Smolen J. Reinisch W, et al. Semin Arthritis Rheum. 2015 Jun;44(6 Suppl):S9-15. doi: 10.1016/j.semarthrit.2015.04.005. Semin Arthritis Rheum. 2015. PMID: 26058551 Free article.
Development of biosimilars.
Al-Sabbagh A, Olech E, McClellan JE, Kirchhoff CF. Al-Sabbagh A, et al. Semin Arthritis Rheum. 2016 Apr;45(5 Suppl):S11-8. doi: 10.1016/j.semarthrit.2016.01.002. Epub 2016 Jan 21. Semin Arthritis Rheum. 2016. PMID: 26947440 Review.
Key considerations in the preclinical development of biosimilars.
Bui LA, Hurst S, Finch GL, Ingram B, Jacobs IA, Kirchhoff CF, Ng CK, Ryan AM. Bui LA, et al. Drug Discov Today. 2015 May;20 Suppl 1:3-15. doi: 10.1016/j.drudis.2015.03.011. Epub 2015 Apr 23. Drug Discov Today. 2015. PMID: 25912284 Review.
431 results